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Abstract:  Hepatic encephalopathy (HE) is the most common complication, and one of the complicating manifestations 
of liver disease. Malnutrition is the most common complication of liver failure. Furthermore, it is a 
prognostic factor (survival rate, length of stay in hospitals and life quality) in cirrhosis patients. The primary 
concept of HE pathogenesis is intestine-derived nitrogen compounds that affect brain function. Daily 
protein intake is a key in HE pathogenesis; therefore, HE patients need nutrient intake in addition to 
medication. 
1 INTRODUCTION 
Hepatic encephalopathy (HE) is the most common 
complication, and one of the complicating 
manifestations of liver disease. The greatest 
challenge is there is no universally accepted standard 
for HE management, particularly major nutrient 
management, due to the lack of clinical research. 
This is a less favorable situation for patients, 
whereas many serious complications are caused by 
cirrhosis (Frederick, 2011). 
Malnutrition is the most common complication 
of liver failure. Furthermore, it is a prognostic factor 
(survival rate, length of stay in hospitals and life 
quality) in cirrhosis patients. Malnutrition incidence 
in cirrhosis ranges from 65-90%. This is due to 
nutritional metabolism disorders occurring in the 
liver, such as increased protein catabolism, increased 
branched-chain amino acid (BCAA) usage, 
decreased ureagenesis, decreased glycogen synthesis 
of muscle and liver, increased gluconeogenesis, 
increased glucose intolerance and insulin resistance, 
increased lipolysis, free fatty acid oxidation and 
increased ketogenesis (Ndraha, Hasan, & 
Simadibrata, 2011). 
The primary concept of HE pathogenesis is 
intestine-derived nitrogen compounds that affect 
brain function. Theoretically, neurotoxins are 
believed to enter the intestine’s systemic circulation 
through the brain barrier, where neurotoxin alters 
astrocytes’ function and morphology. A number of 
neurotoxins, such as ammonia, gamma-aminobutyric 
acid-ergic (GABA-ergic), catecholamine pathways 
and false neurotransmitters, have been shown to play 
a role in experimental HE (Cabral & Burns, 2011). 
Various studies have argued that ammonia, derived 
from daily protein intake, is a key in HE 
pathogenesis. Therefore, HE therapy is based on 
suppressing predisposing factors and decreasing 
ammonia production. The production of intestinal 
ammonia can be suppressed through protein intake 
restriction and lactulose administration which may 
inhibit bacteria producing urease-inhibited enzyme 
(Nguyen & Morgan, 2014). 
2 PATHOGENESIS 
The pathophysiology of hepatic encephalopathy has 
been formulated on accumulation in various toxins 
in the patient's bloodstream and brain. Ammonia is 
believed to be the key molecule causing HE 
(Frederick, 2011). Increased ammonia production in 
the body has long been suspected to originate from 
bacteria colonization that have urease enzyme 
activity, gram-negative anaerobes, 
Enterobacteriaceae, proteus and clostridium. 
Bacterial urease will break down urea coming from 
the bloodstream into ammonia and carbon dioxide. 
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When ammonia is produced by enterocytes and 
bacteria in the colon, ammonia moves through the 
splanchnic vein system to liver for detoxification 
which generally occurs through the urea cycle within 
a hepatocyte zone and through glutamine changes in 
the three-hepatocyte zone (Hasan, 2014). 
Kidneys can also produce ammonia through 
glutamine metabolism via glutaminase into 
ammonia, bicarbonate and glutamate. This ammonia 
formation acts as an acid-base homeostasis since 
bicarbonate is also produced in the cycle; ammonia 
genesis can be an acidosis buffer system (Frederick, 
2011). 
3 DIAGNOSIS 
Hepatic encephalopathy produces a broad spectrum 
of non-specific neurologic and psychiatric 
manifestations. The HE diagnosis may refer to West 
Haven criteria of dividing HE based on its symptom 
degree as seen in Table 1 (Hasan, 2014). 
Table 1: West Haven criteria. 
Degree Cognitive and 
behavior 
Neuromuscular 
function
0 Asymptomatic  None 
1 Sleep disorder, 
decreased 
concentration, 
anxiety and 
irritability 
Monotonous sound, 
tremor, decreased 
writing ability 
2 Lethargy, 
disorientation, 
memory loss 
Ataxia, dysaxia 
3 Somnolen, 
confusion, amnesia, 
emotional distress 
Nystagmus, muscle 
stiffness, 
hyperreflexia or 
hyporeflexia
4 Coma Dilated pupils, 
pathological reflexes
4 NUTRIENTS 
Energy requirements vary in liver cirrhosis patients. 
In general, the energy requirement of patients with 
end-stage hepatic disease is around 120-140% of 
basic energy requirements. The energy requirement 
increases to 150-175% if there is ascites, infection, 
or malabsorption (Idris, 2013). 
Cirrhosis patients also experience increased 
protein usage. A study suggested that the average 
protein requirement to obtain nitrogen balance is 0.8 
grams/kg/day in cirrhosis patients. On the other 
hand, the average protein requirement for hepatitis 
or cirrhosis patients without encephalopathy ranges 
from 0.8-1 gram/kg/day. The patient requires 
nitrogen consumption of 1.2-1.3 grams/kg/day to 
obtain a positive balance. The protein consumption 
is up to 1.5 grams/kg/day under stress conditions 
such as alcohol hepatitis, sepsis, infection, 
gastrointestinal bleeding and ascites (Idris, 2013). 
A prospective randomized control study was 
conducted to examine protein intake differences in 
cirrhotic patients. Among the 62 cohort patients, 15 
patients received normal protein intake and 15 
patients did not receive protein intake. Patients with 
low protein did not receive protein for three days, 
before the protein intake was raised to 1.2 g/kg/day. 
On the other hand, patients with normal protein 
received a standard protein intake of 1.2 g/kg/day. 
At the end of the study, synthesis and protein 
degradation were similar in both groups. 
Biochemical data (including ammonia) and HE 
course were also similar in both groups (Cordoba et 
al., 2004; Nguyen & Morgan, 2014). 
Short-term protein restriction does not degrade 
total body protein or worsen clinical outcomes. In 
refractory HE cases, short-term protein restriction is 
more favorable and does not affect decreased body 
protein (Cordoba et al., 2004; Nguyen & Morgan, 
2014). 
Not all HE patients need dietary protein 
restriction because short-term protein restriction 
does not cause any total body protein breakdown or 
severe clinical condition as protein restriction is only 
performed in HE patients for a short period of time. 
The type of protein consumed is as important as the 
amount of protein consumed (Cordoba et al., 2004; 
Nguyen & Morgan, 2014). A study suggested that 
milk protein can be better tolerated than mixed 
proteins, and vegetable protein is better tolerated 
than animal protein (Riggio et al., 2003). Vegetable 
proteins contain more fiber protein than 
isonitrogenous animal protein. Fiber is able to 
increase food speed through intestines, causing 
increased excretion of fecal ammonia and decreasing 
intestinal luminal pH. Compared to animal protein, 
vegetable protein has a lower amino acid content of 
methionine sulfate and cysteine, which is a 
mercaptan precursor and an indole or oxindole 
compound that serve as the main cause of HE. 
Vegetable proteins are rich in ornithine and arginine 
that facilitate ammonia discharge through the urea 
cycle (Deutz et al., 2014). 
The American Association for the Study of Liver 
Diseases (AASLD) and the European Association 
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for the Study of the Liver (EASL) recommend 
lactulose administration (A1) as a therapy for HE 
patients (Suk et al., 2012). Lactulose works by 
increasing non-urease bacteria growth, such as 
lactobacilli, and lowering intestinal pH. Ammonia in 
the body is as ammonium ion (NH4+) and non-
ammonia ions (NH3). The ratio of this compound is 
determined by blood pH. The more acidic the 
colonic environment increasing the pH gradient, the 
more the ammonia absorption decrease from the gut 
(Elkington, 1970). This procedure corresponds with 
protein restriction in HE patients which are the raw 
material of ammonia. 
Delayed gastric emptying serves as one of 
mechanisms responsible for gastrointestinal 
complaints in hemorrhagic stroke (HS) patients. 
Gastric accommodation disorder is associated with a 
sense of satiety, bloating and epigastric pain 
(Kalaitzakis, 2014). Most HS patients with EH have 
dyspepsia, bloating, nausea and high-protein diet 
intolerance (Nusi, 2015). 
Membrane hyper mealability is found in HS 
patients that subsequently causes HS patients to be 
more susceptible to spontaneous bacterial peritonitis. 
Small bowel motility disorder is also associated with 
intestinal bacteria growth that makes HS patients 
susceptible to infection (Kalaitzakis, 2014). 
Therefore, a high-protein diet is not recommended 
because it is believed to aggravate gastrointestinal 
symptoms and multiply intestinal bacteria. 
It can be inferred that a high-protein diet is not 
recommended for HS patients with EH since protein 
restriction is believed to increase ammonia levels in 
the blood, and short-term protein restriction does not 
degrade total body protein or worsen clinical 
outcomes. 
5 HEPATIC ENCEPHALOPATHY 
DIET 
Decreased ammonia levels and HE clinical 
improvement are significant in the HE diet 
compared to normal proteins. A study found high 
BCAA content in a HE diet and supplementation 
with BCAA infusion on a HE diet can reduce 
ammonia without causing malnutrition that 
subsequently improves clinical HE (Nusi, 2015). 
Other studies found decreased ammonia levels and a 
significant clinical HE improvement after HE diet 
compared to a normal protein diet (Lesmana, 2014; 
Nusi, 2015). 
The HE diet is divided into HE-3, HE-2 and HE-
1 diets. The HE-3 diet contains a nutritional value of 
1,200 calories (10% protein, 42% fat, 48% KH and 
branched-chain amino acid/aromatic amino acid 
(BCAA/AAA) ratio of 2.25). The HE 3-dietary form 
uses enteral administration (feeding tube or liquid). 
The HE-2 diet contains 1,516.7 calories, consisting 
of 12% protein, 33% fat, 55% KH and BCAA/AAA 
ratio of 2.25. The food can be given orally (semi-
liquid). The HE-1 diet has a nutritional value of 
1,577 calories (13% protein, 27% fat, 60% KH and a 
BCAA/AAA ratio of 1.76). The dietary pattern 
includes soft foods plus vegetable and chopped 
protein. The HE diet provided at Dr. Soetomo 
General Hospital Surabaya, Indonesia, is presented 
in Table 2-3 (Nusi, 2015). 
Along with scientific development, particularly 
in the diet for liver cirrhosis patients with HE, the 
results of consensus and the Indonesian Hepatic 
Encephalopathy Clinical Practice Guide published 
by the Indonesian Association for the Study of the 
Liver in 2014 advised revision of the protein intake 
level in the HE diet (Nusi, 2015). The HE diet has 
been revised based on empirical experience as most 
liver cirrhosis patients with HE have dyspepsia, 
bloating, nausea and high-protein diet intolerance. 
Implementation of the HE diet at Dr. Soetomo 
General Hospital, Surabaya, Indonesia, in grade-IV 
hepatic coma patients is HE-3 diet (1,200K) using a 
feeding tube. The HE-3 diet is still administered 
until the patient’s hepatic coma improves to grade II, 
characterized by memory disorder, lethargy, 
dysarthria and flapping tremor in motoric evaluation. 
If the patient’s awareness improves, but 
psychomotor function is still slow as evidenced by a 
bad result of NCT, the HE-2 diet can be 
administered. The HE-2 diet is given when the 
patient is not in HE condition, followed by a hepatic 
diet when the patient is discharged from hospital.
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Table 2: The 2004 hepatic encephalopathy diet. 
Type Calory Protein Administration Indication Parenteral addition
HE-1 diet 
(1700K30P) 
HE-2 diet 
(1400K18P) 
HE-3 diet 
(1200K4P) 
1,700 kcal  
 
1,400 kcal 
 
1,200 kcal  
7% 
 
5% 
 
1%  
Oral 
 
Oral 
 
Feeding tube  
Hepatic precoma 
 
Hepatic precoma (I) 
 
Hepatic coma (II, 
III, IV)
BCAA 
 
BCAA 
 
BCAA  
Table 3: The 2015 hepatic encephalopathy diet 
Type Calory Protein Administration Indication Parenteral addition 
HE-1 diet 
(1577K) 
HE-2 diet 
(1561,7K) 
HE-3 diet 
(1200K) 
1,577 kcal  
 
1,561.7 kcal 
 
1,200 kcal  
13%  
 
12% 
 
10%  
Oral 
 
Oral 
 
Feeding tube  
Resolved hepatic 
precoma 
Hepatic precoma (I) 
 
Hepatic coma (II, 
III, IV)
BCAA 
 
BCAA 
 
BCAA  
 
6 SUMMARY 
Hepatic encephalopathy is the most common 
complication of cirrhosis. The current HE 
pathogenesis still holds that toxin causing HE is due 
to ammonia accumulation as a result of protein 
metabolism. Therefore, HE therapy is performed 
based on precipitant and protein intake restriction. 
Even though some studies have pointed out that 
normal protein administration cannot worsen the 
patient’s clinical outcome, the most current 
consensus recommends short-term protein restriction 
for HE patients. These facts underlie HE diet 
preparation at Dr. Soetomo General Hospital 
Surabaya, Indonesia, and its dietary pattern has been 
applied since 2004. 
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